Title: Inferior Pedicle Breast Reduction: Technical Modifications Leading to Improvements in Patient Safety and Satisfaction in Clinical Outcomes
Target Audience: The intended audience for this activity is plastic surgeons and other healthcare professionals involved in treatment of plastic surgery patients.
Learning Objectives: At the conclusion of this activity participants should be able to:
Michael V. DeFazio, BS
University of Miami
Miller School of Medicine
Miami, Florida
Liliana Camison
Universidad CES
Facultad de Medicina
Medellin, Colombia
Yash J. Avashia, BS
University of Miami
Miller School of Medicine
Miami, Florida
Kenneth Fan, BS
University of Miami
Miller School of Medicine
Miami, Florida
Seth R. Thaller, MD, DMD, FACS
Chief, Division of Plastic and Reconstructive Surgery
University of Miami
Miller School of Medicine
Miami, Florida
This enduring material is approved for 3 years from the date of release, January 26, 2012 to January 25, 2015.
External Reviewers:
Mimis Cohen, MD, FACS, FAAP
Zubin Jal Panthaki, MD, CM, FRACS, FACS
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Michael V. DeFazio, BS
No relevant financial relationship to disclose.
Liliana Camison
No relevant financial relationship to disclose.
Yash J. Avashia, BS
No relevant financial relationships to disclose.
Kenneth Fan, BS
No relevant financial relationship to disclose.
Seth R. Thaller, MD, DMD, FACS
Consulting Fees: Auxilium Pharmaceuticals and Pacira Pharmaceuticals
External reviewer reports the following relationship(s):
Mimis Cohen, MD, FACS, FAAP
No relevant financial relationship to disclose.
Zubin Jal Panthaki, MD, CM, FRACS, FACS
No relevant financial relationship to disclose.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Target Audience: The intended audience for this activity is plastic surgeons and other healthcare professionals involved in treatment of plastic surgery patients.
Learning Objectives: At the conclusion of this activity participants should be able to:
- Describe the historical evolution of current day inferior pedicle breast reduction technique.
- Review anatomical basis and surgical indications for breast reduction procedure.
- Understand technical aspects of inferior pedicle breast reduction starting from preoperative patient markings to postoperative management.
- Describe common complications for inferior pedicle breast reduction and alternative approaches.
Michael V. DeFazio, BS
University of Miami
Miller School of Medicine
Miami, Florida
Liliana Camison
Universidad CES
Facultad de Medicina
Medellin, Colombia
Yash J. Avashia, BS
University of Miami
Miller School of Medicine
Miami, Florida
Kenneth Fan, BS
University of Miami
Miller School of Medicine
Miami, Florida
Seth R. Thaller, MD, DMD, FACS
Chief, Division of Plastic and Reconstructive Surgery
University of Miami
Miller School of Medicine
Miami, Florida
This enduring material is approved for 3 years from the date of release, January 26, 2012 to January 25, 2015.
External Reviewers:
Mimis Cohen, MD, FACS, FAAP
Zubin Jal Panthaki, MD, CM, FRACS, FACS
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Michael V. DeFazio, BS
No relevant financial relationship to disclose.
Liliana Camison
No relevant financial relationship to disclose.
Yash J. Avashia, BS
No relevant financial relationships to disclose.
Kenneth Fan, BS
No relevant financial relationship to disclose.
Seth R. Thaller, MD, DMD, FACS
Consulting Fees: Auxilium Pharmaceuticals and Pacira Pharmaceuticals
External reviewer reports the following relationship(s):
Mimis Cohen, MD, FACS, FAAP
No relevant financial relationship to disclose.
Zubin Jal Panthaki, MD, CM, FRACS, FACS
No relevant financial relationship to disclose.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.